The Neurotechnology Industry 2009 Report

Published by: NeuroInsights, LLC

Published: May. 12, 2009 - 480 Pages

Table of Contents

1: Executive Summary

The Brain Industry Revealed

Neuropharmaceuticals

Neurodevices

Neurodiagnostics

Investment Risks and Opportunities

Translating Neuroscience into Neurotech

The Neurotech Market Opportunity

NASDAQ NeuroInsights Neurotech Index

Neurotechnology and Society

Key Industry Facts and Findings

Market Overview

Industry Overview

Venture Financing

Public Market Activity

Global Growth Drivers

Other Findings

A Brief History of the Science Behind Neurotechnology

2: Trends and Drivers

Converging Technology Drivers

Stem Cells and Neuroregeneration

Neuroimaging, Diagnostics and Disease Treatment

Crossing the Blood Brain Barrier

Demographic Drivers

More People Living Longer

Social Drivers

The Lifestyle Improvement Market

Medical Tourism

Economic Drivers

Global Economic Burden of Brain-Related Illness

Rising Health Care Costs

Research Funding

US Government Research Funding

Stem Cell Funding

International Government Research Funding

Foundations Focus on the Brain

Regulatory Trends

World Regulatory Agencies

Global Clinical Trials

Intellectual Property Trends

Global Intellectual Property Protection

Patent Expirations

Patent Activity in the United States

3: Neuropharmaceutical Sector

Neuropharmaceutical Sector Overview

Trends in Neuropharmaceuticals

Spotlight on Big Pharma

Neuropharmaceutical Partnering and Licensing

Neurology Markets and Pipelines

Alzheimer’s Disease (AD)

AAMI and MCI

Epilepsy and Seizure Disorders

Migraine

Multiple Sclerosis

Parkinson’s Disease

Sleep Disorders

Restless Legs Syndrome

Stroke

Psychiatry Markets and Pipelines

Addiction

Anxiety Disorders

Attention Disorders

Depressive Disorders

Bipolar Disorder

Obesity

Schizophrenia

Cognitive Impairment Associated with Schizophrenia

Sensory Markets and Pipelines

Pain

Retinal Disorders

4: Stem Cells and Neuroregeneration

Defining Stem Cell Markets and Players

Therapeutics

Drug Discovery Tools

Stem Cell Banking

Stem Cell Approaches

Background

The Science of Transplantion

Controlling Immune Rejection and Infection

Sources and Harvesting of Stem Cells

Embronic Stem Cells

Fetal Stem Cells

Adult Stem Cells

Stimulation of Endogenous Stem Cells

Stem Cells Scientific Hurdles

Markets and Treatments in Development

Alzheimer’s Disease

Amyotrophic Lateral Sclerosis (ALS)

Hearing Loss

Huntington’s Disease (HD)

Multiple Sclerosis (MS)

Parkinson’s Disease

Retinal Disorders

Spinal Cord Injury (SCI)

Stroke

Other CNS Diseases

5: Neurodevice Sector

Neurodevice Sector Overview

Neurodevice Markets

FDA Classification and Approval Process

Neurodevice Sector Trends

Neuroprosthetic Devices

Cochlear Implants

Retinal Implants

Motor Prostheses and Brain Computer Interfaces

Neuromodulation Devices

Neuromodulation Device Clinial Trials and Recent Approvals

Deep Brain Stimulation

Essential Tremor

Parkinson’s Disease

Primary Dystonia

Severe Obsessive Compulsive Disorder

Treatment-Resistant Depression

Epilepsy

Traumatic Brain Injury and Stroke

Transcranial Magnetic Stimulation (TMS)

Treatment Resistant Depression

Migraine

Spinal Cord Stimulation (SCS)

Spinal Cord Injury

Vagus Nerve Stimulation (VNS)

Epilepsy

Treatment-Resistant Depression

Obesity

Peripheral Stimulation

Balance

Drug Delivery

Fecal Incontinence

Foot Drop

Hypertension

Migraine

Neuropathic Pain

Restless Legs Syndrome

Sleep Apnea

Stroke

Urinary Conditions

Gastric Modulation and Obesity

Neurosurgical devices

Radiosurgical Devices

Neurosurgical Navigation and Equipment

Image Guided Navigation (IGN)

Intraoperative Magnetic Resonance Imaging (iMRI)

Automated Surgical Systems

Brain Monitoring

Temperature Control Systems

Neurovascular Intervention

Ischemic Stroke

Hemorrhagic Stroke

Neurosoftware

Attention Deficit Disorder

Cognition and Aging

Emotional Wellbeing

Learning Disabilities and Autism

Pain

Abstract

Drugs, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness Markets

Now in its fifth year, The Neurotechnology Industry 2009 Report is an expanded and updated 480 page report of brain and nervous system markets and treatments. It is the only publication to provide a unified market-based framework to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets.

The report includes comprehensive information on products in development globally for over 18 indications at 550 companies including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, and stroke.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.